Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity...
19
Transcript of Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity...
![Page 1: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/1.jpg)
![Page 2: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/2.jpg)
![Page 3: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/3.jpg)
![Page 4: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/4.jpg)
![Page 5: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/5.jpg)
![Page 6: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/6.jpg)
![Page 7: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/7.jpg)
![Page 8: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/8.jpg)
![Page 9: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/9.jpg)
![Page 10: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/10.jpg)
![Page 11: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/11.jpg)
![Page 12: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/12.jpg)
![Page 13: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/13.jpg)
![Page 14: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/14.jpg)
![Page 15: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/15.jpg)
![Page 16: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/16.jpg)
![Page 17: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/17.jpg)
![Page 18: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/18.jpg)
![Page 19: Preliminary Safety and Activity in a Phase 1 study of BLU ... · 12/4/2016 · Anti-tumor activity in KIT-driven mastocytoma modeli Vehicle BLU-285 0.3 mg/kg PO ... 130 Patients](https://reader035.fdocuments.us/reader035/viewer/2022081613/5fbd8cf4e984270be81b9c3e/html5/thumbnails/19.jpg)